Royal Society of Canada Class of 2020
The Royal Society of Canada announces Dr. Maziar Divangahi as one of its newest members to the College of New Scholars
According to the WHO, respiratory disorders are leading causes of death world-wide (second only to heart attack & stroke). These include diseases such as obstructive lung diseases and pulmonary infections. As a result, our research is focused around four main pulmonary research themes. These include: chronic airways disease, lung injury and infection, neuromuscular dysfunction in respiratory diseases, and sleep-disordered breathing.
Above all, a multidisciplinary approach is used to study the basic mechanisms of a number of diseases. These include asthma, chronic obstructive pulmonary disease, pulmonary infections, cystic fibrosis, sleep apnea, respiratory muscle disorders, pulmonary fibrosis, lung injury, and rare respiratory diseases. Research at the Meakins also involves the study of human physiology and tissues in parallel with relevant animal and cell culture models. Furthermore, research is facilitated by the availability of a variety of core facilities for both clinical and fundamental studies.
Learn more about our research themes here.
Below you will see posts and news items related to our research themes.
The Royal Society of Canada announces Dr. Maziar Divangahi as one of its newest members to the College of New Scholars
Dr. Irah King discusses disease tolerance in light of the recent COVID-19 pandemic and why some weather the infection unscathed
Dr. Jean Bourbeau is leading a new Phase III clinical trial with dapson to target lung inflammation caused by COVID-19
Dr. Peter Goldberg receives an Innovation grant to build a clinical-grade ventilator that can be produced cheaply and easily
Dr. Dick Menzie’s team of PDFs contributed to a study in the Lancet on HIV and TB medications
Dr. Goldberg in La Presse – COVID-19 patients’ experiences post-ICU: enduring side effects and a long recovery.
Dr. Annie C. Lajoie, Resident with Dr. Marta Kaminska has been awarded an ATS ASPIRE Fellowship
Dr. Carolyn Baglole received a CIHR catalyst grant from the recent Health Effects of Vaping competition
Dr. Bill Powell’s preclinical research program on small molecule OXE receptor antagonists acquired by Liminal BioSciences
Jean-Philippe Leduc-Gaudet awarded the Journal of Physiology’s 2019 Early Investigator prize.